ALECTOR INC. - COMMON STOCK

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 Oct 2022 16:30:00 By Nasdaq GlobeNewswire

Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)

12 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

07 Sep 2022 07:00:01 By Nasdaq GlobeNewswire

Alector Reports Second Quarter 2022 Financial Results and Provides Business Update

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

08 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

27 May 2022 16:30:00 By Nasdaq GlobeNewswire

Alector Reports First Quarter 2022 Financial Results and Provides Business Update

05 May 2022 16:05:02 By Nasdaq GlobeNewswire

Alector to Participate at the BofA Securities 2022 Healthcare Conference

04 May 2022 07:00:01 By Nasdaq GlobeNewswire

Alector Announces Appointment of Gary Romano, M.D., Ph.D., as Chief Medical Officer

29 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial

15 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Alector to Present at Upcoming Healthcare Conferences

09 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Alector to Present New AL001 Data at AD/PD™ 2022

08 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

01 Mar 2022 16:30:00 By Nasdaq GlobeNewswire

Alector to Participate at the Cowen 42nd Annual Health Care Conference

01 Mar 2022 16:05:02 By Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2021 Financial Results

24 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Alector Announces Appointment of Marc Grasso, M.D., as Chief Financial Officer

07 Feb 2022 08:30:00 By Nasdaq GlobeNewswire

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

03 Jan 2022 16:30:00 By Nasdaq GlobeNewswire

Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development

15 Dec 2021 08:30:00 By Nasdaq GlobeNewswire

Alector Presents Encouraging New AL001 Data from the Symptomatic FTD-GRN Cohort of INFRONT-2 Phase 2 Open-label Clinical Study

12 Nov 2021 13:50:00 By Nasdaq GlobeNewswire

Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer’s 36th Annual Meeting

12 Nov 2021 07:00:03 By Nasdaq GlobeNewswire